BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34346283)

  • 1. Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis.
    Bajaj JS; Shamsaddini A; Fagan A; McGeorge S; Gavis E; Sikaroodi M; Brenner LA; Wade JB; Gillevet PM
    Gut Microbes; 2021; 13(1):1953247. PubMed ID: 34346283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.
    Bajaj JS; Saeian K; Schubert CM; Hafeezullah M; Franco J; Varma RR; Gibson DP; Hoffmann RG; Stravitz RT; Heuman DM; Sterling RK; Shiffman M; Topaz A; Boyett S; Bell D; Sanyal AJ
    Hepatology; 2009 Oct; 50(4):1175-83. PubMed ID: 19670416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Area Deprivation Index and Gut-Brain Axis in Cirrhosis.
    Bajaj JS; Fagan A; McGeorge S; Sterling RK; Rogal S; Sikaroodi M; Gillevet PM
    Clin Transl Gastroenterol; 2022 Jun; 13(6):e00495. PubMed ID: 35537854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
    Bajaj JS; Fagan A; White MB; Wade JB; Hylemon PB; Heuman DM; Fuchs M; John BV; Acharya C; Sikaroodi M; Gillevet PM
    Am J Gastroenterol; 2019 Jul; 114(7):1080-1090. PubMed ID: 30816877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.
    Bajaj JS; Sikaroodi M; Fagan A; Heuman D; Gilles H; Gavis EA; Fuchs M; Gonzalez-Maeso J; Nizam S; Gillevet PM; Wade JB
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G661-G669. PubMed ID: 31460790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis.
    Jinato T; Sikaroodi M; Fagan A; Sterling RK; Lee H; Puri P; Davis BC; Fuchs M; Gavis E; Gillevet PM; Bajaj JS
    Gut Microbes; 2023 Dec; 15(2):2288168. PubMed ID: 38010871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.
    Ahluwalia V; Wade JB; Heuman DM; Hammeke TA; Sanyal AJ; Sterling RK; Stravitz RT; Luketic V; Siddiqui MS; Puri P; Fuchs M; Lennon MJ; Kraft KA; Gilles H; White MB; Noble NA; Bajaj JS
    Metab Brain Dis; 2014 Dec; 29(4):1017-25. PubMed ID: 24590688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis.
    Luo M; Hu FR; Xin RJ; Yao L; Hu SJ; Bai FH
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):797-807. PubMed ID: 35942803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microbiota in hepatic encephalopathy.
    Bajaj JS
    Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
    Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
    PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
    Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
    J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient.
    Sharma P; Kumar A
    Saudi J Gastroenterol; 2012; 18(5):316-21. PubMed ID: 23006459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
    Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
    Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
    Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
    World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy.
    Bloom PP; Luévano JM; Miller KJ; Chung RT
    Ann Hepatol; 2021; 25():100333. PubMed ID: 33621653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.